Gallium has three radioisotopes of interest for medical imaging, 67 Ga (t 1/2 = 3.25 days), 66 Ga (t 1/2 = 9.5 h) and 68 Ga (t 1/2 = 68 min). The first one, a γ emitter, can be used in γ-scintigraphy, while the others, being β + emitters, are appropriate for positron emission tomography (PET). 68 Ga is a very attractive radionuclide for PET, as it can be produced in situ from a 68 Tc-generator. Galliumbased radiopharmaceuticals preparation is easy and fast, contrarily to the preparation of 18 F or 11 C covalently labeled PET agents, leading to a minimum loss of activity.
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The most common chelators for Ga(III) are hexadentate 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] and, among them, triaza macrocycles are specially suitable due to their high conformational and size selectivities, allowing a good fit of the relatively small cation in the macrocyclic cavity.
Such is the case of 1,4,7-triazacyclononane-N,N´,N´´-triacetic acid (NOTA) 5 , which forms highly stable chelates and allows a faster incorporation of Ga(III) at lower temperatures than 1,4,7,10-tetraazacyclododecane-N,N´,N´´,N'''-tetraacetic acid (DOTA), its tetraaza analog. 18 Recently we reported the synthesis and study of micelles forming Ga(III) chelates of NOTA-based ligands with a variable size α-alkyl chain in one of the acetate arms. 4 The synthetic route of these ligands is compatible with their conjugation to amine-containing biomolecules, rendering them bifunctional chelators. Bifunctional chelators are molecules displaying a targeting vector with high affinity and selectivity for a specific receptor and a metal ion that can be used for diagnosis or therapy.
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Amongst biomolecules, peptides have shown to be the most effective targeting moieties known for cellular receptors, drug delivery, molecular imaging and radiotherapeutic applications. [20] [21] [22] [23] The compatibility with peptide synthesis requires that bifunctional chelators, often bearing carboxylic acid groups, offer the possibility of orthogonal protection.
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The arginine-glycine-aspartic (RGD) peptide sequence has emerged as one of the most efficient epitopes for targeting the integrin   3 receptor. Integrin    3 receptor is a transmembrane protein that acts as a receptor for extracellular matrix proteins with RGD tripeptide sequence. [25] [26] This integrin is highly expressed in active endothelial cells of the neovasculature of various tumors and it has been demonstrated that it is overexpressed in both endothelial cells and tumor cells in human breast cancer xenografts. 27 The integrin    3 receptor expression correlates well with tumor progression and invasiveness of melanoma, glioma, ovarian and breast cancers. 25, 27 Due to the restricted expression of    3 in tumors, this integrin is considered an adequate molecular target for tumor targeting.
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In this paper we report an efficient synthetic route for coupling NOTA-based pro-chelators to peptides. As proof-of-concept we have used as a model peptide a linear glycine-argine-glycine-aspartic-glycine (GRGDG) pentapeptide. Three conjugates were obtained ( Fig. 1 ) and their radiolabeling with 67 Ga has been characterized; stability and hydrophilicity studies have been performed. In vitro studies with a human glioblastoma cell line complemented this work.
The NOTA conjugates were prepared according to the strategy presented in GRGDG which demonstrated that these chelates are moderately hydrophilic (logP = -2.66 and logP = -1.30, respectively). These results are in accordance with our previous studies and correlate with the different lengths of the -alkyl side chain. 4 The human glioblastoma (U87MG) cell line is known to overexpress the   3 receptor. 33 In this experiment, we evaluated the interaction of 29 This value was reduced to 0.14 ± 0.01 when the cells were treated with echistatin indicating that, despite the low affinity of the bioconjugate, we are facing a specific process.
In conclusion, we synthesized three NOTA-based conjugates of a model GRGDG peptide adequate for radiolabeling with Ga(III), which are targeted to the integrin    3 receptor . The synthetic route that was used makes use of an orthogonal protection strategy that may also be efficiently applied to DOTA-based chelators (referir artigo do André?) and to other peptides. 35 Potentially, the presence of a pendant α-alkyl chain in the chelator moiety has an effect on the pharmacokinetic properties of the correspondent Ga(III) labeled conjugates, and these might be tuned in accordance to the number of carbon atoms of the chain. Despite the fact that one of the triaza carboxylic groups is used for conjugation to the peptide, through amide bond formation, the Ga(III) 
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